Mallick R - Search Results

1

Safety and efficacy of apixaban thromboprophylaxis in ambulatory cancer patients according to renal function: A subgroup analysis of the AVERT trial.

Wang TF, Mallick R, Carrier M, Wells PS. Wang TF, et al. Among authors: mallick r. Thromb Res. 2022 Mar;211:85-87. doi: 10.1016/j.thromres.2022.01.022. Epub 2022 Jan 31. Thromb Res. 2022. PMID: 35124234 Clinical Trial.

2

A survey of the use of empiric novel anticoagulants during investigation of stroke.

van Gaal S, Carrier M, Rodriguez RA, Sharma M, Mallick R, Stotts G, Dowlatshahi D. van Gaal S, et al. Among authors: mallick r. Can J Neurol Sci. 2015 Mar;42(2):135-7. doi: 10.1017/cjn.2015.14. Can J Neurol Sci. 2015. PMID: 25804250 No abstract available.

3

"HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?

Rodger MA, Le Gal G, Langlois NJ, Gin B, Mallick R, Giulivi A, Freedman M, Kovacs MJ; REVERSE II investigators. Rodger MA, et al. Among authors: mallick r. Thromb Res. 2018 Sep;169:82-86. doi: 10.1016/j.thromres.2018.07.020. Epub 2018 Jul 17. Thromb Res. 2018. PMID: 30031290 Free article.

4

Venous thromboembolism and transfusion after major abdominopelvic surgery.

McAlpine K, Breau RH, Knee C, Carrier M, Violette PD, van Walraven C, McIsaac DI, Mallick R, Cagiannos I, Morash C, Lavallée LT. McAlpine K, et al. Among authors: mallick r. Surgery. 2019 Dec;166(6):1084-1091. doi: 10.1016/j.surg.2019.05.050. Epub 2019 Jul 31. Surgery. 2019. PMID: 31377000

5

Biomarkers in cancer patients at risk for venous thromboembolism: data from the AVERT study.

Ilich A, Kumar V, Henderson M, Mallick R, Wells P, Carrier M, Key NS. Ilich A, et al. Among authors: mallick r. Thromb Res. 2020 Jul;191 Suppl 1:S31-S36. doi: 10.1016/S0049-3848(20)30394-7. Thromb Res. 2020. PMID: 32736776 Clinical Trial.

6

D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with Cancer.

Kumar V, Shaw JR, Key NS, Ilich A, Mallick R, Wells PS, Carrier M. Kumar V, et al. Among authors: mallick r. Oncologist. 2020 Dec;25(12):1075-1083. doi: 10.1002/onco.13540. Epub 2020 Oct 12. Oncologist. 2020. PMID: 32969580 Free PMC article. Clinical Trial.

7

Biomarker-enhanced VTE risk stratification in ambulatory patients with cancer.

Shaw JR, Kumar V, Mallick R, Carrier M, Ilich A, Key NS, Wells P. Shaw JR, et al. Among authors: mallick r. Thromb Res. 2020 Dec;196:437-443. doi: 10.1016/j.thromres.2020.09.035. Epub 2020 Oct 8. Thromb Res. 2020. PMID: 33065408

8

Thromboprophylaxis for patients with newly diagnosed vs. recurrent cancers: a post-hoc analysis of the avert trial.

Zhang J, Atalla M, Mallick R, Wells PS, Carrier M. Zhang J, et al. Among authors: mallick r. J Thromb Thrombolysis. 2021 Apr;51(3):720-724. doi: 10.1007/s11239-020-02317-y. Epub 2020 Oct 20. J Thromb Thrombolysis. 2021. PMID: 33079379 Clinical Trial.

9

Safety and efficacy of apixaban thromboprophylaxis in cancer patients with metastatic disease: A post-hoc analysis of the AVERT trial.

Knoll W, Mallick R, Wells PS, Carrier M. Knoll W, et al. Among authors: mallick r. Thromb Res. 2021 Jan;197:13-15. doi: 10.1016/j.thromres.2020.10.026. Epub 2020 Nov 1. Thromb Res. 2021. PMID: 33160115 Clinical Trial.

10

Efficacy and safety of apixaban for primary prevention in gastrointestinal cancers: A post-hoc analysis of the AVERT trial.

Ladha D, Mallick R, Wang TF, Caiano L, Wells PS, Carrier M. Ladha D, et al. Among authors: mallick r. Thromb Res. 2021 Jun;202:151-154. doi: 10.1016/j.thromres.2021.03.013. Epub 2021 Mar 21. Thromb Res. 2021. PMID: 33857789 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

407 results

Search Page

Filters